Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
HouseofCards's Profile
Displaying 1-50 of 302 result(s).
CYDY CytoDyn Inc
10/08/2025 1:30:25 AM
Biloxi, I believe you said you were (10)
CYDY CytoDyn Inc
10/02/2025 12:48:00 PM
Any thoughts as to why Quest would
CYDY CytoDyn Inc
10/02/2025 11:28:20 AM
For what it's worth, ChatGPT did st (6)
CYDY CytoDyn Inc
10/02/2025 12:58:20 AM
With all of the theories on why we (11)
CYDY CytoDyn Inc
10/02/2025 12:26:51 AM
I understood the protocol to mean t (6)
CYDY CytoDyn Inc
10/02/2025 12:22:01 AM
I thought this didn't happen until (1)
CYDY CytoDyn Inc
09/29/2025 6:11:09 PM
I believe 3 out of 5 patients showe (3)
CYDY CytoDyn Inc
09/29/2025 5:34:46 PM
Ohm, am I remembering correctly tha (8)
CYDY CytoDyn Inc
09/23/2025 1:49:38 PM
I'm not one of the scientific guys (19)
CYDY CytoDyn Inc
09/23/2025 12:30:27 AM
The ORR for 3rd line treatment in m (3)
CYDY CytoDyn Inc
09/10/2025 1:12:10 AM
I thought you could based on share (1)
CYDY CytoDyn Inc
09/09/2025 10:41:27 PM
This may be an unpopular opinion, b (6)
CYDY CytoDyn Inc
09/05/2025 1:15:30 AM
No offense but this is a completely (18)
CYDY CytoDyn Inc
08/19/2025 11:34:20 PM
I know we've heard rumors about qui (14)
CYDY CytoDyn Inc
08/19/2025 2:37:54 PM
Something MGK and Ken were talking (3)
CYDY CytoDyn Inc
08/02/2025 12:07:50 AM
So, according to UWS on r/Livimmune (3)
CYDY CytoDyn Inc
07/25/2025 6:04:36 PM
I asked if Dr. JL's statement about (3)
CYDY CytoDyn Inc
07/25/2025 5:25:27 PM
The CTC page hasn't been updated si (2)
CYDY CytoDyn Inc
07/25/2025 4:46:52 PM
Enrollment is not going how we hope (7)
CYDY CytoDyn Inc
07/23/2025 9:39:53 PM
We can still sell like 250M shares (2)
CYDY CytoDyn Inc
07/16/2025 12:39:26 AM
The fiscal year end was May 31.
CYDY CytoDyn Inc
07/07/2025 1:27:13 PM
I would expect updates on any or al (4)
CYDY CytoDyn Inc
07/02/2025 11:14:35 AM
Correct me if I'm wrong, but if the (1)
CYDY CytoDyn Inc
07/02/2025 1:33:23 AM
All this appears to say is that the (2)
CYDY CytoDyn Inc
06/30/2025 11:08:45 AM
What kind of ORR do you think we wo (1)
CYDY CytoDyn Inc
06/24/2025 2:24:36 PM
The inclusion criteria looks pretty (3)
CYDY CytoDyn Inc
06/17/2025 10:11:52 AM
Nowhere in that statement does he s (9)
CYDY CytoDyn Inc
06/04/2025 2:11:43 AM
Question for the science guys that (6)
CYDY CytoDyn Inc
06/02/2025 11:26:29 AM
This was my thought, and that ESMO (2)
CYDY CytoDyn Inc
05/29/2025 10:07:18 PM
I think recruiting means they're sc (6)
CYDY CytoDyn Inc
05/29/2025 8:19:06 PM
Unfortunately, I don't know anythin
CYDY CytoDyn Inc
05/29/2025 6:55:20 PM
Depends on the amount of credits. I (2)
CYDY CytoDyn Inc
05/29/2025 6:38:14 PM
You can sell tax credits to raise f (2)
CYDY CytoDyn Inc
05/29/2025 2:42:06 AM
Shareholder letters have been comin (4)
CYDY CytoDyn Inc
05/22/2025 12:44:02 AM
Forgive my ignorance, are they allo (1)
CYDY CytoDyn Inc
05/20/2025 2:09:37 PM
Played around with ChatGPT about a (10)
CYDY CytoDyn Inc
05/19/2025 1:20:44 PM
So now than ESMO is over and unders
CYDY CytoDyn Inc
05/14/2025 8:57:38 PM
Ohm, I may be misunderstanding what (19)
CYDY CytoDyn Inc
05/12/2025 4:36:09 PM
CRC trial is now recruiting on Clin (22)
CYDY CytoDyn Inc
05/08/2025 1:08:18 PM
That's what I take it to mean. Hope (4)
CYDY CytoDyn Inc
05/02/2025 12:59:17 AM
"Median overall survival is calcula (4)
CYDY CytoDyn Inc
05/01/2025 1:34:44 PM
I think out of the whole 28 patient (6)
CYDY CytoDyn Inc
04/30/2025 6:09:57 PM
Sean is correct, if we still have p (6)
CYDY CytoDyn Inc
04/30/2025 10:34:07 AM
Anyone can feel free to correct me (17)
CYDY CytoDyn Inc
04/30/2025 10:11:27 AM
I had a discussion with ChatGPT who (11)
CYDY CytoDyn Inc
04/30/2025 1:45:50 AM
I think our poster presentation tim (3)
CYDY CytoDyn Inc
04/30/2025 1:39:16 AM
I added another 100k shares on Mond (6)
CYDY CytoDyn Inc
04/29/2025 4:07:26 PM
From the PR on 11/8/21: 4 subjects (4)
CYDY CytoDyn Inc
04/27/2025 1:54:02 AM
I'm prefacing this by saying that I (13)
CYDY CytoDyn Inc
04/24/2025 7:48:55 PM
Question: The original PR about our
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • NANO Nuclear Energy Prepares for Major Conferences in November
  • Strengthening Alliances: The New US-India Defense Agreement
  • AI Adoption and Job Cuts: Insights from Goldman Sachs Survey
  • LyondellBasell's Q3 Financial Update: Navigating Challenges
  • TXNM Energy's Q3 Performance Highlights and Future Directions
  • Lear Corporation's Robust Q3 2025 Financial Performance
  • TXNM Energy's Q3 Results: Growth and Strategic Updates
  • Lear Corporation's Remarkable Q3 2025 Performance Report
  • 2026 Travel Trends Unveiled: A Curated Experience Awaits
  • The Future of Agriculture Biotechnology: Sustainable Growth Insights
  • Exploring Next Year's Travel Trends with Skyscanner Insights
  • Exciting Highlights from the Consumer Retail Sector This Week
  • Exploring the Future of Investment in Orphan Drugs Market
  • Navigating Investment Disclosure: Insights on Dowlais Group plc
  • Unlocking the Future of Rare Disease Therapies Through Innovation
  • Cenovus Energy's Remarkable Q3 Performance Highlights
  • Sagrada Familia's Tower of Jesus Christ Sees Major Progress
  • Shanghai Electric Advances Global Fusion Energy Projects for Sustainability
  • Exploring Key Financial Releases Impacting the Market
  • Essential Health News Highlights You Shouldn't Miss This Week
  • Scandinavian Tobacco Group Welcomes New Board Member
  • Hepsiburada Set to Reveal Q3 Financial Performance Soon
  • Exploring Growth and Innovative Strategies in Biotech Antibodies
  • Fable Security Achieves Recognition with Two Industry Awards
  • Tenvels Launches Innovative E-Bikes and Digital Platform
  • Transformative Journey: ZĂ©nabou's Path to Education Inclusion
  • New Inducement Grants by IDEAYA Biosciences Enhance Talent Growth
  • Solidion Technology Achieves NASDAQ Compliance Success
  • Get Ready for the Exciting Oddities and Curiosities Expo 2026
  • Latest Press Breakthroughs: OpenAI Partners with PayPal
  • Pixalate Unveils Market Share Leaders in North America's SSPs
  • Exploring the Growth and Investment Potential in Antibody Markets
  • Cenovus Energy Reports Record Q3 Results: A Positive Trajectory
  • Hepsiburada's Innovative Impact on E-Commerce and Women Empowerment
  • Immuron Updates on Clinical Trials for Travelan and IMM-529
  • AS Tallinna Vesi Shares Insights at Investor Conference Webinar
  • BOOST Pharma's Breakthrough in Osteogenesis Imperfecta Treatment
  • Market Pulse: Key Stock Movements Featuring Amazon and Apple
  • AskGamblers Casino Service Enhances Player Satisfaction
  • AskGamblers Casino Service Delivers Impressive Player Restitution
  • Shanghai Electric Leads the Charge in Nuclear Fusion Innovation
  • Amazon's Stock Surge: Insights on Market Movers Today
  • Palantir Targets Ex-Workers for Allegedly Stealing AI Secrets
  • Treasury Bill Auction Results: Insight into Recent Sales
  • Samsung Chairman's Humorous Take on iPhone Popularity
  • Riot Platforms Shifts Focus: From Bitcoin Mining to Data Centers
  • Magna's Q3 2025 Financial Results Show Resilience and Growth
  • Aurora Mobile Enhances Travel with Tuniu's Intelligent Push Tech
  • Municipality Finance Maintains Strong Capital Position Amid Changes
  • Magna International Posts Strong Q3 2025 Financial Performance
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site